Call toll-free 800.328.1267
Market Insights has covered the split between the new winners and losers in technology. Something similar seems to be underway in the health-care sector. Drug makers whose products offer the promise of growth have led. These includes biotechnology stocks, which keep...
A hospital company drowning in liabilities just reported good results. Now a trader is using options to position for a comeback. Here's a breakdown of the strategy detected yesterday afternoon in Community Health (CYH): 20,000 September 4 puts were sold for...
Something unusual is happening with prices, and it's become good news for certain companies this year. Inflation data from the government shows the price of services rose 2.7 percent year over year in January, while commodities had their first drop since November...
Initial public offerings have faced a double-whammy of challenges, but now experts expect a pickup. First, the stock market ended 2019 with its worst quarterly drop in over seven years. Volatility like that is a challenge for any company going public, but it was...
Biotechnology stocks are ripping in 2019, fueled by some high-profile takeovers. It was only the second trading session of the year that Bristol Myers Squibb (BMY) gobbled up Celgene (CELG) in a record $74 billion deal. Loxo Oncology (LOXO) accepted an $8 billion bid...
Big growth stocks are roaring back to life as earnings approach. Companies like Netflix (NFLX), Incyte (INCY), Broadcom (AVGO), Facebook (FB) and Alphabet (GOOGL) are leading the S&P 500 higher today as investors return to the most important part of the market....
Suddenly small is beautiful in the eyes of investors. Indexes focused on smaller companies, like the Russell 2000 (IWM) or the Nasdaq Composite ($COMPX), have outperformed larger benchmarks like the S&P 500 ($SPX.X) and Dow Jones Industrial Average ($INDU) since...
No, it wasn't a nightmare. There was a lot of bad news on a lot of companies last week. At least five of the 30 members of the Dow Jones Industrial Average dropped amid some kind of bearish headline: Apple (AAPL): Wall Street analysts continued to hammer the...
Everyone's been focused on the selloff in tech, but something more bullish may be happening in a forgotten corner of the market. Large pharmaceutical companies including Pfizer (PFE), Merck (MRK) and Amgen (AMGN) have formed triangles in recent weeks. The...
Cannabis stocks, all the rage in September, just issued their results. And they're spending a ton of money. Just look at Tilray (TLRY), which rose more than a 1,000 percent after going public in the heart of the marijuana frenzy. Its revenue from growing pot rose 85...